UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-22338
(Exact name of registrant as specified in charter)
100 International Drive, Baltimore, MD, 21202
(Address of principal executive offices) (Zip code)
Marc A. De Oliveira
Franklin Templeton
100 First Stamford Place
Stamford, CT 06902
(Name and address of agent for service)
Registrant’s telephone number, including area code: 877-6LM-FUND/656-3863
Date of fiscal year end: July 31
Date of reporting period:
ITEM 1. | REPORT TO STOCKHOLDERS. |
(a) | The Report to Shareholders is filed herewith |
|
![]() |
|
Semi-Annual Shareholder Report |
|
||
![]() |
Fund Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*,†
|
Martin Currie SMASh Series EM Fund1
|
$
|
|
* | Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
† | Annualized. |
1 | Does not reflect the effect of fees and expenses associated with a separately managed account, or a management fee or other operating expenses of the Fund. |
Total Net Assets
|
$
|
Total Number of Portfolio Holdings*
|
|
Portfolio Turnover Rate
|
|
* | Does not include derivatives, except purchased options, if any. |
* | Does not include derivatives, except purchased options, if any. |
![]() |
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
Additional information is available on
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
Martin Currie SMASh Series EM Fund | PAGE 1 | 7280-STSR-0325 |
(b) | Not applicable |
ITEM 2. | CODE OF ETHICS. |
Not applicable.
ITEM 3. | AUDIT COMMITTEE FINANCIAL EXPERT. |
Not applicable.
Item 4. | Principal Accountant Fees and Services. |
Not applicable.
ITEM 5. | AUDIT COMMITTEE OF LISTED REGISTRANTS. |
Not applicable.
ITEM 6. | SCHEDULE OF INVESTMENTS. |
(a) | Please see schedule of investments contained in the Financial Statements and Financial Highlights included under Item 7 of this Form N-CSR. |
(b) | Not applicable. |
ITEM 7. | FINANCIAL STATEMENTS AND FINANCIAL HIGLIGHTS FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
1
| |
4
| |
5
| |
6
| |
7
| |
8
| |
16
| |
16
| |
16
|
Security
|
|
|
|
Shares
|
Value
|
Common
Stocks — 98.9% | |||||
Consumer
Discretionary — 13.7% | |||||
Automobiles
— 4.3% | |||||
Maruti
Suzuki India Ltd. |
|
303,658
|
$43,020,293
(a)
| ||
Broadline
Retail — 3.2% | |||||
MercadoLibre
Inc. |
|
16,423
|
31,568,126
*
| ||
Textiles,
Apparel & Luxury Goods — 6.2% | |||||
Titan
Co. Ltd. |
|
1,541,095
|
61,841,979
(a)
| ||
| |||||
Total
Consumer Discretionary |
136,430,398
| ||||
Consumer
Staples — 3.2% | |||||
Beverages
— 1.6% | |||||
Eastroc
Beverage Group Co. Ltd., Class A Shares |
|
478,700
|
16,040,169
(a)
| ||
Consumer
Staples Distribution & Retail — 0.2% | |||||
Robinsons
Retail Holdings Inc. |
|
3,314,690
|
1,942,035
| ||
Personal
Care Products — 1.4% | |||||
Proya
Cosmetics Co. Ltd., Class A Shares |
|
1,198,560
|
13,891,814
(a)
| ||
| |||||
Total
Consumer Staples |
31,874,018
| ||||
Energy
— 6.2% | |||||
Oil,
Gas & Consumable Fuels — 6.2% | |||||
Reliance
Industries Ltd. |
|
4,256,013
|
61,937,173
(a)
| ||
| |||||
Financials
— 15.2% | |||||
Banks
— 12.8% | |||||
Al
Rajhi Bank |
|
2,146,333
|
56,607,708
(a)
| ||
Kotak
Mahindra Bank Ltd. |
|
1,676,871
|
36,673,425
(a)
| ||
Shinhan
Financial Group Co. Ltd. |
|
984,390
|
34,290,055
(a)
| ||
Total
Banks |
127,571,188
| ||||
Capital
Markets — 2.4% | |||||
B3
SA - Brasil Bolsa Balcao |
|
12,326,700
|
23,391,844
| ||
| |||||
Total
Financials |
150,963,032
| ||||
Health
Care — 7.3% | |||||
Health
Care Equipment & Supplies — 0.9% | |||||
Shenzhen
Mindray Bio-Medical Electronics Co. Ltd., Class A Shares |
|
282,800
|
9,095,030
(a)
| ||
Health
Care Providers & Services — 6.4% | |||||
Apollo
Hospitals Enterprise Ltd. |
|
451,748
|
35,430,321
(a)
| ||
Dr
Sulaiman Al Habib Medical Services Group Co. |
|
173,739
|
13,535,216
| ||
Odontoprev
SA |
|
7,590,520
|
14,612,016
| ||
Total
Health Care Providers & Services |
63,577,553
| ||||
| |||||
Total
Health Care |
72,672,583
|
Security
|
|
|
|
Shares
|
Value
|
| |||||
Industrials
— 6.9% | |||||
Electrical
Equipment — 4.1% | |||||
Contemporary
Amperex Technology Co. Ltd., Class A Shares |
|
1,146,468
|
$40,876,634
(a)
| ||
Machinery
— 2.8% | |||||
Shenzhen
Inovance Technology Co. Ltd., Class A Shares |
|
3,336,846
|
27,782,538
(a)
| ||
| |||||
Total
Industrials |
68,659,172
| ||||
Information
Technology — 37.3% | |||||
Electronic
Equipment, Instruments & Components — 3.0% | |||||
Delta
Electronics Inc. |
|
2,265,000
|
29,513,052
(a)
| ||
IT
Services — 3.7% | |||||
Tata
Consultancy Services Ltd. |
|
783,293
|
37,064,273
(a)
| ||
Semiconductors
& Semiconductor Equipment — 14.8% | |||||
Globalwafers
Co. Ltd. |
|
1,842,000
|
18,983,174
(a)
| ||
MediaTek
Inc. |
|
875,000
|
37,893,671
(a)
| ||
SK
Hynix Inc. |
|
673,080
|
90,616,529
(a)
| ||
Total
Semiconductors & Semiconductor Equipment |
147,493,374
| ||||
Technology
Hardware, Storage & Peripherals — 15.8% | |||||
Quanta
Computer Inc. |
|
3,947,000
|
31,292,344
(a)
| ||
Samsung
Electronics Co. Ltd. |
|
1,913,181
|
68,326,816
(a)
| ||
Samsung
Electronics Co. Ltd., Registered Shares, GDR |
|
65,100
|
58,197,396
(a)
| ||
Total
Technology Hardware, Storage & Peripherals |
157,816,556
| ||||
| |||||
Total
Information Technology |
371,887,255
| ||||
Materials
— 9.1% | |||||
Chemicals
— 1.3% | |||||
LG
Chem Ltd. |
|
79,284
|
12,858,725
*(a)
| ||
Construction
Materials — 3.8% | |||||
UltraTech
Cement Ltd. |
|
284,284
|
37,594,018
(a)
| ||
Metals
& Mining — 4.0% | |||||
Antofagasta
PLC |
|
1,892,482
|
40,128,998
(a)
| ||
| |||||
Total
Materials |
90,581,741
| ||||
Total
Investments before Short-Term Investments (Cost — $936,527,620) |
985,005,372
| ||||
|
|
Rate
|
|
|
|
Short-Term
Investments — 1.7% | |||||
Western
Asset Institutional U.S. Treasury Reserves,
Institutional
Shares (Cost — $16,661,629)
|
4.216%
|
|
16,661,629
|
16,661,629
(b)(c)
| |
Total
Investments — 100.6% (Cost — $953,189,249) |
1,001,667,001
| ||||
Liabilities
in Excess of Other Assets — (0.6)% |
(6,123,979
) | ||||
Total
Net Assets — 100.0% |
$995,543,022
|
*
|
Non-income producing
security. |
(a)
|
Security is
fair valued in accordance with procedures approved by the Board of Trustees (Note
1). |
(b)
|
Rate shown is
one-day yield as of the end of the reporting period.
|
(c)
|
In this instance,
as defined in the Investment Company Act of 1940, an “Affiliated
Company”
represents Fund
ownership of
at least 5% of the outstanding voting securities of an issuer, or a company which is under common
ownership or
control with the Fund. At January 31, 2025, the total market value of investments in Affiliated
Companies was
$16,661,629 and the cost was $16,661,629 (Note 6).
|
Abbreviation(s)
used in this schedule: | ||
GDR
|
—
|
Global
Depositary Receipts |
Summary
of Investments by Country#
| |
India
|
31.3
% |
South
Korea |
26.4
|
Taiwan
|
11.7
|
China
|
10.8
|
Saudi
Arabia |
7.0
|
Brazil
|
6.9
|
Chile
|
4.0
|
Philippines
|
0.2
|
Short-Term
Investments |
1.7
|
|
100.0
% |
#
|
As a percentage
of total investments. Please note that the Fund holdings are as of January 31, 2025, and are
subject to change.
|
Assets:
|
|
Investments
in unaffiliated securities, at value (Cost — $936,527,620) |
$985,005,372
|
Investments
in affiliated securities, at value (Cost — $16,661,629) |
16,661,629
|
Foreign
currency, at value (Cost — $1,858,108) |
1,859,356
|
Cash
|
100,000
|
Receivable
for Fund shares sold |
5,782,399
|
Dividends
receivable from unaffiliated investments |
2,314,849
|
Receivable
from investment manager |
129,517
|
Dividends
receivable from affiliated investments |
45,209
|
Receivable
for securities sold |
2,269
|
Prepaid
expenses |
27,771
|
Total
Assets |
1,011,928,371
|
Liabilities:
|
|
Accrued
foreign capital gains tax |
9,785,738
|
Payable
for securities purchased |
5,589,763
|
Payable
for Fund shares repurchased |
952,088
|
Trustees’
fees payable |
6,766
|
Accrued
expenses |
50,994
|
Total
Liabilities |
16,385,349
|
Total
Net Assets |
$995,543,022
|
Net
Assets: |
|
Par
value (Note
5) |
$1,107
|
Paid-in
capital in excess of par value |
1,282,035,286
|
Total
distributable earnings (loss) |
(286,493,371
) |
Total
Net Assets |
$995,543,022
|
Shares
Outstanding |
110,695,711
|
Net
Asset Value |
$8.99
|
Investment
Income: |
|
Dividends
from unaffiliated investments |
$7,894,742
|
Dividends
from affiliated investments |
198,282
|
Other
income |
6,619
|
Less:
Foreign taxes withheld |
(1,200,375
) |
Total
Investment Income |
6,899,268
|
Expenses:
|
|
Custody
fees |
235,793
|
Interest
expense |
54,131
|
Fund
accounting fees |
48,227
|
Legal
fees |
33,536
|
Trustees’
fees |
30,877
|
Registration
fees |
25,859
|
Audit
and tax fees |
15,822
|
Shareholder
reports |
6,881
|
Commitment
fees (Note
7) |
5,962
|
Transfer
agent fees (Note 2) |
318
|
Miscellaneous
expenses |
3,252
|
Total
Expenses |
460,658
|
Less:
Fee waivers and/or expense reimbursements (Note 2)
|
(460,658
) |
Net
Expenses |
—
|
Net
Investment Income |
6,899,268
|
Realized
and Unrealized Gain (Loss) on Investments and Foreign Currency Transactions
(Notes
1 and 3): | |
Net
Realized Loss From: |
|
Investment
transactions in unaffiliated securities |
(54,413,694
)† |
Foreign
currency transactions |
(1,000,671
) |
Net
Realized Loss |
(55,414,365
) |
Change
in Net Unrealized Appreciation (Depreciation) From: |
|
Investments
in unaffiliated securities |
(89,759,575
)‡ |
Foreign
currencies |
134,885
|
Change
in Net Unrealized Appreciation (Depreciation)
|
(89,624,690
) |
Net
Loss on Investments and Foreign Currency Transactions
|
(145,039,055
) |
Decrease
in Net Assets From Operations |
$(138,139,787
) |
†
|
Net of foreign
capital gains tax of $1,526,066. |
‡
|
Net of change
in accrued foreign capital gains tax of $(4,440,988).
|
For
the Six Months Ended January 31, 2025 (unaudited)
and
the Year Ended July 31, 2024 |
2025
|
2024
|
Operations:
|
|
|
Net
investment income |
$6,899,268
|
$18,545,329
|
Net
realized loss |
(55,414,365
) |
(100,016,368
) |
Change
in net unrealized appreciation (depreciation)
|
(89,624,690
) |
93,790,808
|
Increase
(Decrease) in Net Assets From Operations |
(138,139,787
) |
12,319,769
|
Distributions
to Shareholders From (Note
1): |
|
|
Total
distributable earnings |
(12,000,062
) |
(16,000,193
) |
Decrease
in Net Assets From Distributions to Shareholders |
(12,000,062
) |
(16,000,193
) |
Fund
Share Transactions (Note
5): |
|
|
Net
proceeds from sale of shares
|
195,371,198
|
518,097,289
|
Cost
of shares repurchased
|
(412,016,145
) |
(420,445,492
) |
Increase
(Decrease) in Net Assets From Fund Share
Transactions
|
(216,644,947
) |
97,651,797
|
Increase
(Decrease) in Net Assets |
(366,784,796
) |
93,971,373
|
Net
Assets: |
|
|
Beginning
of period |
1,362,327,818
|
1,268,356,445
|
End
of period |
$995,543,022
|
$1,362,327,818
|
For
a share of beneficial interest outstanding throughout each year ended July 31,
unless
otherwise noted: | ||||||
|
20251,2
|
20241
|
20231
|
20221
|
20211
|
20201
|
Net
asset value, beginning of period |
$10.27
|
$10.35
|
$9.47
|
$13.23
|
$9.03
|
$8.14
|
Income
(loss) from operations: | ||||||
Net
investment income |
0.06
|
0.14
|
0.14
|
0.16
|
0.18
|
0.16
|
Net
realized and unrealized gain (loss) |
(1.23
) |
(0.10
) |
0.84
|
(3.54
) |
4.08
|
0.81
|
Total
income (loss) from operations |
(1.17)
|
0.04
|
0.98
|
(3.38)
|
4.26
|
0.97
|
Less
distributions from: |
|
|
|
|
|
|
Net
investment income |
(0.11
) |
(0.12
) |
(0.05
) |
(0.11
) |
(0.06
) |
(0.08
) |
Net
realized gains |
—
|
—
|
(0.05
) |
(0.27
) |
—
|
—
|
Total
distributions |
(0.11
) |
(0.12
) |
(0.10
) |
(0.38
) |
(0.06
) |
(0.08
) |
Net
asset value, end of period |
$8.99
|
$10.27
|
$10.35
|
$9.47
|
$13.23
|
$9.03
|
Total
return3
|
(11.37
)% |
0.47
% |
10.51
% |
(26.21
)% |
47.25
% |
11.92
% |
Net
assets, end of period (millions) |
$996
|
$1,362
|
$1,268
|
$1,100
|
$1,007
|
$185
|
Ratios
to average net assets: | ||||||
Gross
expenses4
|
0.08
%5
|
0.06
%6
|
0.10
%7
|
0.09
% |
0.09
% |
0.35
% |
Net
expenses8,9
|
0.00
5
|
0.00
6,10
|
0.00
7
|
0.00
|
0.00
|
0.00
|
Net
investment income |
1.22
5,10
|
1.45
6
|
1.45
7
|
1.43
|
1.48
|
2.03
|
Portfolio
turnover rate |
17
% |
26
% |
12
% |
27
% |
33
% |
27
% |
1
|
Per share amounts
have been calculated using the average shares method. |
2
|
For the six
months ended January 31, 2025 (unaudited). |
3
|
Performance
figures do not reflect the effect of fees and expenses associated with a separately managed account,
nor a management
fee or other operating expenses of the Fund. Such management fees are paid directly or
indirectly by
the separately managed account sponsor to the Fund’s manager or subadviser. All operating expenses
of the Fund
were reimbursed by the manager, pursuant to an expense reimbursement arrangement between the
Fund and the
manager. If such fees were included, the total return would have been lower. Past performance is no
guarantee of
future results. Total returns for periods of less than one year are not annualized. |
4
|
Gross expenses
do not include management fees paid to the manager and subadviser. Management fees are paid
directly or
indirectly by the separately managed account sponsor. |
5
|
Annualized.
|
6
|
Ratio includes
the impact of fees paid indirectly. In the absence of these fees, the gross and net expense ratios and
the net investment
income ratio would have been 0.03%, 0.00% and 1.45%, respectively. |
7
|
Ratio includes
the impact of fees paid indirectly. In the absence of these fees, the gross and net expense ratios and
the net investment
income ratio would have been 0.06%, 0.00% and 1.45%, respectively. |
8
|
The Fund’s
manager has entered into an expense reimbursement arrangement with the Fund, pursuant to which the
Fund’s
manager has agreed to reimburse 100% of the Fund’s ordinary operating expenses. The expense
reimbursement
arrangement does not cover interest, brokerage commissions, taxes, extraordinary expenses and
acquired fund
fees and expenses. This arrangement cannot be terminated prior to December 31, 2026 without the
Board of Trustees’
consent. |
9
|
Reflects fee
waivers and/or expense reimbursements. |
10
|
The manager
has agreed to waive the Fund’s management fee to an extent sufficient to offset the net management
fee payable
in connection with any investment in an affiliated money market fund. |
ASSETS
| ||||
Description
|
Quoted
Prices
(Level
1) |
Other
Significant
Observable
Inputs
(Level
2)* |
Significant
Unobservable
Inputs
(Level
3) |
Total
|
Long-Term
Investments†: |
|
|
|
|
Common
Stocks: |
|
|
|
|
Consumer
Discretionary |
$31,568,126
|
$104,862,272
|
—
|
$136,430,398
|
Consumer
Staples |
1,942,035
|
29,931,983
|
—
|
31,874,018
|
Financials
|
23,391,844
|
127,571,188
|
—
|
150,963,032
|
Health
Care |
28,147,232
|
44,525,351
|
—
|
72,672,583
|
Other
Common Stocks |
—
|
593,065,341
|
—
|
593,065,341
|
Total
Long-Term Investments |
85,049,237
|
899,956,135
|
—
|
985,005,372
|
Short-Term
Investments† |
16,661,629
|
—
|
—
|
16,661,629
|
Total
Investments |
$101,710,866
|
$899,956,135
|
—
|
$1,001,667,001
|
*
|
As
a result of the fair value pricing procedures for international equities utilized by the Fund, which account for
events
occurring after the close of the principal market of the security but prior to the calculation of the Fund’s
net
asset value, certain securities were classified as Level 2 within the fair value hierarchy. |
†
|
See
Schedule of Investments for additional detailed categorizations. |
Purchases
|
$186,497,415
|
Sales
|
365,519,124
|
|
Cost
|
Gross
Unrealized
Appreciation
|
Gross
Unrealized
Depreciation
|
Net
Unrealized
Depreciation
|
Securities
|
$1,025,941,158
|
$149,801,132
|
$(174,075,289)
|
$(24,274,157)
|
|
Six
Months Ended
January
31, 2025 |
Year
Ended
July
31, 2024 |
Shares
sold |
21,314,613
|
52,816,369
|
Shares
repurchased |
(43,334,685
) |
(42,632,606
) |
Net
increase (decrease) |
(22,020,072
) |
10,183,763
|
|
Affiliate
Value at
July 31, 2024 |
Purchased |
Sold
| ||
Cost |
Shares |
Proceeds |
Shares |
||
Western
Asset
Institutional
U.S.
Treasury
Reserves,
Institutional
Shares
|
$17,950,556
|
$214,418,742
|
214,418,742
|
$215,707,669
|
215,707,669
|
(cont’d)
|
Realized
Gain (Loss) |
Dividend
Income |
Net Increase
(Decrease) in
Unrealized
Appreciation
(Depreciation)
|
Affiliate
Value at
January 31,
2025 |
Western
Asset
Institutional
U.S.
Treasury
Reserves,
Institutional
Shares |
—
|
$198,282
|
—
|
$16,661,629
|
ITEM 8. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR.
ITEM 9. | PROXY DISCLOSURES FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR.
ITEM 10. | REMUNERATION PAID TO DIRECTORS, OFFICERS, AND OTHERS OF OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR.
ITEM 11. | STATEMENT REGARDING BASIS FOR APPROVAL OF INVESTMENT ADVISORY CONTRACT. |
The information is disclosed as part of the Financial Statements included in Item 7 of this Form N-CSR, as applicable.
ITEM 12. | DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
ITEM 13. | PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
ITEM 14. | PURCHASES OF SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS. |
Not applicable.
ITEM 15. | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. |
Not applicable.
ITEM 16. | CONTROLS AND PROCEDURES. |
(a) | The registrant’s principal executive officer and principal financial officer have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a- 3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) are effective as of a date within 90 days of the filing date of this report that includes the disclosure required by this paragraph, based on their evaluation of the disclosure controls and procedures required by Rule 30a-3(b) under the 1940 Act and 15d-15(b) under the Securities Exchange Act of 1934. |
(b) | There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected, or are likely to materially affect the registrant’s internal control over financial reporting. |
ITEM 17. | DISCLOSURE OF SECURITIES LENDING ACTIVITIES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
ITEM 18. | RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION. |
(a) | Not applicable. |
(b) | Not applicable. |
ITEM 19. | EXHIBITS. |
(a) (1) Not applicable.
Exhibit 99.CODE ETH
(a) (2) Certifications pursuant to section 302 of the Sarbanes-Oxley Act of 2002 attached hereto.
Exhibit 99.CERT
(b) Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 attached hereto.
Exhibit 99.906CERT
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this Report to be signed on its behalf by the undersigned, there unto duly authorized.
Legg Mason Global Asset Management Trust
By: | /s/ Jane Trust | |
Jane Trust | ||
Chief Executive Officer |
Date: | March 24, 2025 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/ Jane Trust | |
Jane Trust | ||
Chief Executive Officer |
Date: | March 24, 2025 |
By: | /s/ Christopher Berarducci | |
Christopher Berarducci | ||
Principal Financial Officer |
Date: | March 24, 2025 |